
When Medicine Becomes a Risk: Lessons from the Cold Syrup Tragedy
In recent weeks, Indian pharmaceutical manufacturer Sresan Pharma has come under public

In recent weeks, Indian pharmaceutical manufacturer Sresan Pharma has come under public

What Every Pharma Executive Should Know At the 2025 FDA Generic Drugs

What’s Changing Why It Matters What Companies Should Do Now Executive Recommendation

A new report commissioned by the U.S. pharmaceutical trade group warns that

This could change how diabetes is managed across the U.S. The future

Leveling the Global Playing Field FDA Expands Unannounced Foreign Inspections-Are you Ready?
 
				
			
			CEO & President
Sign up for our monthly newsletter for the latest news & articles
Copyright ©2025 LST Consulting USA. All Rights Reserved Copyright